These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 25091073)
1. Lifetime risk of hospital diagnosed chronic obstructive pulmonary disease in remote Aboriginal people: a cohort study. Wang Z; Hoy WE Aust N Z J Public Health; 2014 Aug; 38(4):340-3. PubMed ID: 25091073 [TBL] [Abstract][Full Text] [Related]
2. Complex impact of remoteness on the incidence of myocardial infarction in Aboriginal and non-Aboriginal people in Western Australia. Katzenellenbogen JM; Sanfilippo FM; Hobbs MS; Briffa TG; Knuiman MW; Dimer L; Thompson PL; Thompson SC Aust J Rural Health; 2012 Dec; 20(6):305-11. PubMed ID: 23181814 [TBL] [Abstract][Full Text] [Related]
3. Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a population-based cohort study. Shen TC; Lin CL; Chen CH; Tu CY; Hsia TC; Shih CM; Hsu WH; Sung FC QJM; 2014 Jul; 107(7):537-43. PubMed ID: 24497528 [TBL] [Abstract][Full Text] [Related]
4. Chronic Obstructive Pulmonary Disease In Aboriginal Patients Of The Northern Territory Of Australia: A Landscape Perspective. Heraganahally SS; Wasgewatta SL; McNamara K; Eisemberg CC; Budd RC; Mehra S; Sajkov D Int J Chron Obstruct Pulmon Dis; 2019; 14():2205-2217. PubMed ID: 31576117 [TBL] [Abstract][Full Text] [Related]
5. COPD in the general population: prevalence, incidence and survival. Afonso AS; Verhamme KM; Sturkenboom MC; Brusselle GG Respir Med; 2011 Dec; 105(12):1872-84. PubMed ID: 21852081 [TBL] [Abstract][Full Text] [Related]
6. Estimating chronic disease prevalence among the remote Aboriginal population of the Northern Territory using multiple data sources. Zhao Y; Connors C; Wright J; Guthridge S; Bailie R Aust N Z J Public Health; 2008 Aug; 32(4):307-13. PubMed ID: 18782390 [TBL] [Abstract][Full Text] [Related]
7. Incidence and prevalence of chronic obstructive pulmonary disease among aboriginal peoples in Alberta, Canada. Ospina MB; Voaklander D; Senthilselvan A; Stickland MK; King M; Harris AW; Rowe BH PLoS One; 2015; 10(4):e0123204. PubMed ID: 25875817 [TBL] [Abstract][Full Text] [Related]
8. C-reactive protein and the risk of developing type 2 diabetes in Aboriginal Australians. Wang Z; Hoy WE Diabetes Res Clin Pract; 2007 Apr; 76(1):37-43. PubMed ID: 16952410 [TBL] [Abstract][Full Text] [Related]
9. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Gershon AS; Warner L; Cascagnette P; Victor JC; To T Lancet; 2011 Sep; 378(9795):991-6. PubMed ID: 21907862 [TBL] [Abstract][Full Text] [Related]
10. Variations in hospitalizations for chronic obstructive pulmonary disease in rural and urban Victoria, Australia. Ansari Z; Dunt D; Dharmage SC Respirology; 2007 Nov; 12(6):874-80. PubMed ID: 17986117 [TBL] [Abstract][Full Text] [Related]
11. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Wang Z; Hoy WE Med J Aust; 2005 Jan; 182(2):66-9. PubMed ID: 15651963 [TBL] [Abstract][Full Text] [Related]
12. Incidence of first heart failure hospitalisation and mortality in Aboriginal and non-Aboriginal patients in Western Australia, 2000-2009. Teng TH; Katzenellenbogen JM; Thompson SC; Sanfilippo FM; Knuiman M; Geelhoed E; Hobbs M; Bessarab D; Hung J Int J Cardiol; 2014 Apr; 173(1):110-7. PubMed ID: 24630335 [TBL] [Abstract][Full Text] [Related]
13. A nationwide cohort study of the risk of chronic obstructive pulmonary disease in coeliac disease. Ludvigsson JF; Inghammar M; Ekberg M; Egesten A J Intern Med; 2012 May; 271(5):481-9. PubMed ID: 21880073 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of chronic obstructive pulmonary disease in Cyprus: a population-based study. Zachariades AG; Zachariadou T; Adamide T; Anagnostopoulou U; Georgiou A; Gourgoulianis KI COPD; 2012 Jun; 9(3):259-67. PubMed ID: 22432899 [TBL] [Abstract][Full Text] [Related]
15. Hospital use in Aboriginal and non-Aboriginal patients with chronic disease. Whyatt D; Yap M; Tenneti R; Pearson G; Vickery A Emerg Med Australas; 2017 Oct; 29(5):516-523. PubMed ID: 28419735 [TBL] [Abstract][Full Text] [Related]
16. Homocysteine, renal disease and cardiovascular disease in a remote Australian Aboriginal community. McDonald S; Maguire G; Duarte N; Wang XL; Hoy W Intern Med J; 2005 May; 35(5):289-94. PubMed ID: 15845111 [TBL] [Abstract][Full Text] [Related]
17. C-reactive protein: an independent predictor of cardiovascular disease in Aboriginal Australians. Wang Z; Hoy WE Aust N Z J Public Health; 2010 Jul; 34 Suppl 1():S25-9. PubMed ID: 20618287 [TBL] [Abstract][Full Text] [Related]
18. Decreasing rates of natural deaths in a remote Australian Aboriginal community, 1996-2010. Wang Z; Hoy WE Aust N Z J Public Health; 2013 Aug; 37(4):365-70. PubMed ID: 23895480 [TBL] [Abstract][Full Text] [Related]
19. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Shirtcliffe P; Marsh S; Travers J; Weatherall M; Beasley R Intern Med J; 2012 Jan; 42(1):83-8. PubMed ID: 20403069 [TBL] [Abstract][Full Text] [Related]
20. Aboriginal to non-Aboriginal differentials in 2-year outcomes following non-fatal first-ever acute MI persist after adjustment for comorbidity. Katzenellenbogen JM; Sanfilippo FM; Hobbs MS; Briffa TG; Ridout SC; Knuiman MW; Dimer L; Taylor KP; Thompson PL; Thompson SC Eur J Prev Cardiol; 2012 Oct; 19(5):983-90. PubMed ID: 21798989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]